Many chemicals, both natural and man-made, have the potential to imitate or interfere with the endocrine system, which regulates the body’s hormones. These chemicals, known as endocrine disruptors, have been linked to developmental, reproductive, brain, immunological, and other disorders. Endocrine disruptors can be present in a variety of ordinary items, such as some plastic bottles and containers, metal food can liners, detergents, flame retardants, food, toys, cosmetics, and pesticides. Pesticides, chemicals, and environmental toxins are screened using a two-tiered method for their potential effect on the estrogen, androgen, and thyroid hormone systems by the endocrine disruptor screening.
Charles River Laboratories, Inc. and SGS SA — Notable Market Players in Endocrine Disruption Screening Market
The growth of the market is attributed to growing research in the biotechnology sector and growing prevalence of endocrine disorders drive the market growth. However, the high cost of screening technology hampers the market growth.
Market leaders operating in the market have undertaken various organic and inorganic growth strategies. The endocrine disruptor screening market majorly consists of players like Creative Bioarray, Eurofins Scientific, Alpha Analytical, Inc., JRF Global, Xenometrix AG, SGS SA. Smithers, and Mérieux NutriSciences.
Several in organic approaches, such as product launches, and expansion in the endocrine disruptor screening, have resulted in the growth of the market. Likewise, inorganic strategies such as mergers & acquisitions, and collaboration have helped the company to strengthen its revenue, which allows the company to hold a strong position in the market.
A few growth strategies adopted by the players operating in the endocrine disruptor screening market are listed below:
| Month and Year | Description |
| Jan-2021 | Charles River Laboratories International, Inc. announced its strategic partnership with Cypre, Inc., a biotechnology company. The partnership will provide Charles River clients with access to Cypre’s proprietary 3D tumor model platform, Falcon-X, which will expand Charles River’s 3D in vitro testing services to further optimize immuno-oncological approaches for its clients. |
| Jun-2021 | Smithers, a leading provider of testing, consulting, information, and compliance services, acquired SSP, a highly respected and well-known service provider with a global network and an abundance of experience in solid fuels, metals, and minerals. This acquisition enables Smithers to enter the dry commodities testing, analysis, inspection, and supervision market. The acquisition includes all Ssp operations, including offices and laboratories at the headquarters in the Netherlands and Ssp Italy. |
| Jul-2021 | Mérieux NutriSciences, a world leader in food safety, quality, and sustainability, acquired Tracelab SpA., a laboratory offering specialized analytical services to the salmon farming industry in Chile. With the acquisition of Tracelab SpA., Mérieux NutriSciences Chile expands its presence in the Chilean market for salmon farming and salmon feed producers. |
| Jul-2021 | DDA platform, the division of Creative Bioarray, launched a wide range of genotoxicity testing services (non-GLP) into the service segment of in vitro toxicity services. Genotoxicity testing services are for the application in drug discovery research. |
